BIOAVAILABILITY OF COMMERCIAL TETRACYCLINE PRODUCTS

被引：9

作者：

BARNETT, DB

SMITH, RN

GREENWOOD, ND

HETHERINGTON, C

机构：

[1] UNIV SHEFFIELD, ROY INFIRM, ACAD DIV MED, SECT THERAPEUTICS, SHEFFIELD S6 3DA, ENGLAND

[2] GEN INFIRM, PHARM DEPT, GT GEORGE ST, LEEDS LS1 3EX, ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1974年 / 1卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.1974.tb00260.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：319 / 323

页数：5

共 16 条

[1] SERUM LEVELS OF TETRACYCLINE AFTER DIFFERENT ADMINISTRATION FORMS [J].

ALTMANN, AE ;

BEEUWKES, H ;

BROMBACHER, PJ ;

BUYTENDIJK, HJ ;

GIJZEN, AHJ ;

MAESEN, FPV .

CLINICA CHIMICA ACTA, 1968, 20 (02) :185-+

[2]

BARR WH, 1972, CLIN PHARMACOL THER, V13, P97

[3]

BERGEN T, 1972, ACTA PHARMACOL TOX, V33, P138

[4] BIOLOGICAL AVAILABILITY OF OXYTETRACYCLINE HCL CAPSULES - COMPARISON OF ALL MANUFACTURING SOURCES SUPPLYING UNITED-STATES MARKET [J].

BLAIR, DC ;

BARNES, RW ;

WILDNER, EL ;

MURRAY, WJ .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 215 (02) :251-&

[5] THERAPEUTIC NONEQUIVALENCE OF OXYTETRACYCLINE CAPSULES [J].

BRICE, GW ;

HAMMER, HF .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (07) :1189-&

[6] DIRECT PROPORTIONALITY OF URINARY EXCRETION RATE AND SERUM LEVEL OF TETRACYCLINE IN HUMAN SUBJECTS [J].

CHULSKI, T ;

JOHNSON, RH ;

WAGNER, JG ;

SCHLAGEL, CA .

NATURE, 1963, 198 (487) :450-&

[7]

Groves M.J., 1973, PHARM J, V210, P318

[8] DETERMINATION OF TETRACYCLINES BY EXTRACTION OF FLUORESCENT COMPLEXES - APPLICATION TO BIOLOGICAL MATERIALS [J].

KOHN, KW .

ANALYTICAL CHEMISTRY, 1961, 33 (07) :862-&

[9] DISTRIBUTION AND EXCRETION OF 4 TETRACYCLINE ANALOGUES IN NORMAL YOUNG MEN [J].

KUNIN, CM ;

DORNBUSH, AC ;

FINLAND, M .

JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (11) :1950-1963

[10]

MACDONALD H, 1969, CLIN MED/US, V76, P30

← 1 2 →